Empowering progress: a year of gratitude for the European Health and Digital Executive Agency

European Union flags

Share This Post

As 2023 draws to a close, we extend our heartfelt gratitude to the European Health and Digital Executive Agency (HaDEA) for their invaluable support throughout the year.

This year, BIG was thrilled to benefit from an EU4H Operating Grant through the European Health and Digital Executive Agency (HaDEA). This co-financing has supported a significant portion of BIG Headquarters’ activities for 2023. From the successful Pink October “I Miss You” campaign to the further development of the Patient Partnership Initiative and our extensive communication efforts surrounding breast cancer research, the impact of this funding is profound.

We are extremely grateful to the European Commission for their unwavering commitment to our cause. Their support has played a pivotal role in advancing our mission of finding new treatments and, ultimately, cures for breast cancer.

Together, we are making strides towards a future free from the burdens of this disease.

More to explore

Partners collaborating on the AMEERA 6 trial
Press Release

New study: AMEERA-6

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

Dr Gustavo Werutsky breast international group

Interview with Dr. Gustavo Werutsky

Meet Dr. Gustavo Werutsky, who joined BIG’s Executive Board last year. Dr. Werutsky shared his journey, professional insights, and the motivation behind his involvement with